UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SP0187 Why Missing Data Is A Problem, and What You shouldn't Do To Solve It

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.45-45

Frisell, T.

2016

Volltextzugriff (PDF)

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

JAMA neurology, 2020, Vol.77 (2), p.184

2020

Volltextzugriff (PDF)

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Annals of neurology, 2016-06, Vol.79 (6), p.950-958

2016

Volltextzugriff (PDF)

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Annals of neurology, 2020, Vol.87 (5), p.688-699

2020

Volltextzugriff (PDF)

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial

JAMA neurology, 2022-11, Vol.79 (11), p.1105

2022

Volltextzugriff (PDF)

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

Rheumatology (Oxford, England), 2022-10, Vol.61 (10), p.3952-3962

2022

Volltextzugriff (PDF)

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.601-610

2023

Volltextzugriff (PDF)

Violent crime runs in families: a total population study of 12.5 million individuals

Psychological medicine, 2011-01, Vol.41 (1), p.97-105

2011

Volltextzugriff (PDF)

The Association Between Schizophrenia and Rheumatoid Arthritis: A Nationwide Population-Based Swedish Study on Intraindividual and Familial Risks

Schizophrenia bulletin, 2014-11, Vol.40 (6), p.1552-1559

2014

Volltextzugriff (PDF)

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.650-657

2018

Volltextzugriff (PDF)

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

Rheumatology (Oxford, England), 2022, Vol.61 (9), p.3596-3605

2022

Volltextzugriff (PDF)

Invited Commentary: Sibling-Comparison Designs, Are They Worth the Effort?

American journal of epidemiology, 2021-05, Vol.190 (5), p.738-741

Frisell, Thomas

2021

Volltextzugriff (PDF)

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Journal of neurology, neurosurgery and psychiatry, 2024, Vol.95 (2), p.134-141

2024

Volltextzugriff (PDF)

OP0231 Gastro-intestinal perforations among rheumatoid arthritis patients treated with biologic dmards: a nationwide swedish cohort study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.164

2018

Volltextzugriff (PDF)

Familial clustering of suicide risk: a total population study of 11.4 million individuals

Psychological medicine, 2011-12, Vol.41 (12), p.2527-2534

2011

Volltextzugriff (PDF)

Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New‐Onset Rheumatoid Arthritis: A Nested Case–Control Study

Arthritis & rheumatology (Hoboken, N.J.), 2015-11, Vol.67 (11), p.2845-2854

2015

Volltextzugriff (PDF)

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

Rheumatology (Oxford, England), 2019, Vol.58 (8), p.1367-1377

2019

Volltextzugriff (PDF)

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

European journal of neurology, 2019-08, Vol.26 (8), p.1060-1067

2019

Volltextzugriff (PDF)

Hospital Admission With Infection During Childhood and Risk for Psychotic Illness—A Population-based Cohort Study

Schizophrenia bulletin, 2014-11, Vol.40 (6), p.1518-1525

2014

Volltextzugriff (PDF)

Psychiatric morbidity associated with same-sex sexual behaviour: influence of minority stress and familial factors

Psychological medicine, 2010-02, Vol.40 (2), p.315-324

2010

Volltextzugriff (PDF)

OP0122 COMPARATIVE EFFECTIVENESS OF JAKI VERSUS BDMARDS; A NATIONWIDE STUDY IN RA

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.68-68

2021

Volltextzugriff (PDF)

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Journal of clinical oncology, 2018-06, Vol.36 (18), p.1847-1852

2018

Volltextzugriff (PDF)

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

Rheumatology (Oxford, England), 2024, Vol.63 (5), p.1221-1229

2024

Volltextzugriff (PDF)

Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study

Scandinavian journal of rheumatology, 2022, Vol.51 (1), p.10-20

2022

Volltextzugriff (PDF)

1 – 25 von 670

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(580)
Mit Volltextzugriff
(490)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

SP0187 Why Missing Data Is A Problem, and What You shouldn't Do To Solve It

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

Violent crime runs in families: a total population study of 12.5 million individuals

The Association Between Schizophrenia and Rheumatoid Arthritis: A Nationwide Population-Based Swedish Study on Intraindividual and Familial Risks

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

Invited Commentary: Sibling-Comparison Designs, Are They Worth the Effort?

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

OP0231 Gastro-intestinal perforations among rheumatoid arthritis patients treated with biologic dmards: a nationwide swedish cohort study

Familial clustering of suicide risk: a total population study of 11.4 million individuals

Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New‐Onset Rheumatoid Arthritis: A Nested Case–Control Study

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

Hospital Admission With Infection During Childhood and Risk for Psychotic Illness—A Population-based Cohort Study

Psychiatric morbidity associated with same-sex sexual behaviour: influence of minority stress and familial factors

OP0122 COMPARATIVE EFFECTIVENESS OF JAKI VERSUS BDMARDS; A NATIONWIDE STUDY IN RA

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study

Suchergebnisse filtern